Publications by authors named "Ruicheng Lv"

Claim this Profile
T
The discovery of novel imidazo[1,2-]pyridine derivatives as covalent anticancer agents.
Qin Song, Qianer Zhang, Xuejing Fan, Fatmata Kayaat, Ruicheng Lv

Org Biomol Chem· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis and biological evaluation of novel indolin-2-one derivatives as potent second-generation TRKs inhibitors.
Qiaohua Qin, Qinglin Fu, Xin Wang, Ruicheng Lv, Shuyu Lu

Eur J Med Chem· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and biological evaluation of aminopyridine derivatives as novel tropomyosin receptor kinase inhibitors.
Ruicheng Lv, Xin Wang, Yixiang Sun, Qiaohua Qin, Nian Liu

Arch Pharm (Weinheim)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis and biological evaluation of pyrazolo[3,4-]pyridine derivatives as TRK inhibitors.
Nian Liu, Xin Wang, Qinglin Fu, Qiaohua Qin, Tianxiao Wu, Ruicheng Lv

RSC Med Chem· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and biological evaluation of potent FAK-degrading PROTACs.
Qiaohua Qin, Ruifeng Wang, Qinglin Fu, Guoqi Zhang, Tianxiao Wu, Ruicheng Lv

J Enzyme Inhib Med Chem· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of quinazoline derivatives CZw-124 as a pan-TRK inhibitor with potent anticancer effects in vitro and in vivo.
Tianxiao Wu, Qiaohua Qin, Ruicheng Lv, Nian Liu, Wenbo Yin

Eur J Med Chem· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and biological evaluation of coumarin analogs as novel LSD1 inhibitors.
Yixiang Sun, Ruicheng Lv, Tianxiao Wu, Xiangyu Zhang, Yin Sun

Arch Pharm (Weinheim)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational drug design to explore the structure-activity relationship (SAR) of TRK inhibitors with 2,4-diaminopyrimidine scaffold.
Tianxiao Wu, Qiaohua Qin, Nian Liu, Chu Zhang, Ruicheng Lv

Eur J Med Chem· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, biological evaluation and pharmacophore model analysis of novel tetrahydropyrrolo[3,4-c]pyrazol derivatives as potential TRKs inhibitors.
Tianxiao Wu, Chu Zhang, Ruicheng Lv, Qiaohua Qin, Nian Liu

Eur J Med Chem· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats.
Dan Hu, Changqiang Zhu, Lele Ai, Ting He, Yi Wang, Ruicheng Lv

Emerg Microbes Infect· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis